These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37897566)

  • 1. Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention.
    Moens de Hase E; Neyrinck AM; Rodriguez J; Cnop M; Paquot N; Thissen JP; Xu Y; Beloqui A; Bindels LB; Delzenne NM; Van Hul M; Cani PD
    Diabetologia; 2024 Feb; 67(2):333-345. PubMed ID: 37897566
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Le Roy T; Moens de Hase E; Van Hul M; Paquot A; Pelicaen R; Régnier M; Depommier C; Druart C; Everard A; Maiter D; Delzenne NM; Bindels LB; de Barsy M; Loumaye A; Hermans MP; Thissen JP; Vieira-Silva S; Falony G; Raes J; Muccioli GG; Cani PD
    Gut; 2022 Mar; 71(3):534-543. PubMed ID: 34108237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipids.
    Moens de Hase E; Petitfils C; Alhouayek M; Depommier C; Le Faouder P; Delzenne NM; Van Hul M; Muccioli GG; Cenac N; Cani PD
    J Lipid Res; 2023 Oct; 64(10):100437. PubMed ID: 37648213
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Le Roy T; Van der Smissen P; Paquot A; Delzenne N; Muccioli GG; Collet JF; Cani PD
    Int J Syst Evol Microbiol; 2020 Sep; 70(9):4851-4858. PubMed ID: 31232680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link between gut microbiota and health outcomes in inulin -treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial.
    Hiel S; Gianfrancesco MA; Rodriguez J; Portheault D; Leyrolle Q; Bindels LB; Gomes da Silveira Cauduro C; Mulders MDGH; Zamariola G; Azzi AS; Kalala G; Pachikian BD; Amadieu C; Neyrinck AM; Loumaye A; Cani PD; Lanthier N; Trefois P; Klein O; Luminet O; Bindelle J; Paquot N; Cnop M; Thissen JP; Delzenne NM
    Clin Nutr; 2020 Dec; 39(12):3618-3628. PubMed ID: 32340903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota.
    Zheng J; Li H; Zhang X; Jiang M; Luo C; Lu Z; Xu Z; Shi J
    J Agric Food Chem; 2018 Jun; 66(23):5821-5831. PubMed ID: 29701959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring.
    Schoonejans JM; Blackmore HL; Ashmore TJ; Pantaleão LC; Pellegrini Pisani L; Dearden L; Tadross JA; Aiken CE; Fernandez-Twinn DS; Ozanne SE
    Diabetologia; 2022 Dec; 65(12):2132-2145. PubMed ID: 36112170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin on metabolic improvement and gut microbiota.
    Lee H; Ko G
    Appl Environ Microbiol; 2014 Oct; 80(19):5935-43. PubMed ID: 25038099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
    Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
    Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
    Zhao X; Zhang X; Pei J; Liu Y; Niu W; Sun H
    Diabetologia; 2023 Nov; 66(11):2139-2153. PubMed ID: 37581618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut commensal
    Wu TR; Lin CS; Chang CJ; Lin TL; Martel J; Ko YF; Ojcius DM; Lu CC; Young JD; Lai HC
    Gut; 2019 Feb; 68(2):248-262. PubMed ID: 30007918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin improves neurobehavioral impairments of streptozotocin-treated and western diet-fed mice: Beyond glucose-lowering effects.
    Delanogare E; Bullich S; Barbosa LADS; Barros WM; Braga SP; Kraus SI; Kasprowicz JN; Dos Santos GJ; Guiard BP; Moreira ELG
    Fundam Clin Pharmacol; 2023 Feb; 37(1):94-106. PubMed ID: 35996325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals.
    Rodriguez J; Neyrinck AM; Van Kerckhoven M; Gianfrancesco MA; Renguet E; Bertrand L; Cani PD; Lanthier N; Cnop M; Paquot N; Thissen JP; Bindels LB; Delzenne NM
    BMC Med; 2022 Mar; 20(1):110. PubMed ID: 35351144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
    Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
    Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Nutritive Sweetened Beverages Impair Therapeutic Benefits of Metformin in Prediabetic Diet-Induced Obese Mice.
    Singh A; Rourk K; Bernier A; de Lartigue G
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21.
    Kim EK; Lee SH; Jhun JY; Byun JK; Jeong JH; Lee SY; Kim JK; Choi JY; Cho ML
    Mediators Inflamm; 2016; 2016():5813030. PubMed ID: 27057099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin.
    Freemark M
    Acta Paediatr; 2007 Sep; 96(9):1326-32. PubMed ID: 17718786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance.
    Hufnagel A; Fernandez-Twinn DS; Blackmore HL; Ashmore TJ; Heaton RA; Jenkins B; Koulman A; Hargreaves IP; Aiken CE; Ozanne SE
    J Physiol; 2022 Feb; 600(4):903-919. PubMed ID: 34505282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.